menu
    • menu

    Company profile for Longeveron

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. We believe regenerative medicine, through cell-based therapy, is a promising new approach to treating these conditions. Participating in FDA-evaluated clinical trials, we are currently testing our cell-based therapy product for a diagnosable ailment called Aging Frailty, a growing condition impacting approximately 50 ...
    Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. We believe regenerative medicine, through cell-based therapy, is a promising new approach to treating these conditions. Participating in FDA-evaluated clinical trials, we are currently testing our cell-based therapy product for a diagnosable ailment called Aging Frailty, a growing condition impacting approximately 50 million Americans over the age of 60.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LongeveronUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1951 NW 7TH AVENUE SUITE 520 MIAMI, FL 33136
    Telephone
    Telephone
    305.909.0840
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.longeveron.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/longeveron-llc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Startup Health Taps Longeveron for Alzheimer's Moonshot
    Startup Health Taps Longeveron for Alzheimer's Moonshot

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210983/0/en/Longeveron-Selected-as-a-StartUp-Health-Alzheimer-s-Disease-Moonshot-Company-Will-Participate-in-StartUp-Health-Apollo-House-During-JPM-Healthcare-Week-2026.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Longeveron Secures U.S. Patent for FSD Stem Cell Therapy
    Longeveron Secures U.S. Patent for FSD Stem Cell Therapy

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3207052/0/en/Longeveron-Granted-U-S-Patent-for-Method-of-Treating-Female-Sexual-Dysfunction-Using-its-Proprietary-Stem-Cell-Therapy.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Longeveron Cso And Cmo To Speak At Global (CVCT) Forum
    Longeveron Cso And Cmo To Speak At Global (CVCT) Forum

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198986/0/en/Longeveron-Chief-Science-Officer-and-Chief-Medical-Officer-Selected-as-Speakers-at-the-Global-CardioVascular-Clinical-Trialists-CVCT-Forum.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Longeveron Receives Canadian Patent For Stem Cell Treatment
    Longeveron Receives Canadian Patent For Stem Cell Treatment

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3198086/0/en/Longeveron-Granted-Canadian-Patent-for-Method-of-Using-Stem-Cells-to-Treat-Non-Ischemic-Dilated-Cardiomyopathy-and-Aging-related-Frailty-in-Patients-with-Inflammaging.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Longeveron Presents New MRI Biomarker Data On Neuroinflammation
    Longeveron Presents New MRI Biomarker Data On Neuroinflammation

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197308/0/en/Longeveron-New-MRI-Biomarker-Data-Linking-Neuroinflammation-to-Clinical-Outcomes-in-Patients-with-Mild-Alzheimer-s-Disease-Presented-at-the-Clinical-Trials-on-Alzheimer-s-Disease-C.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Longeveron's Laromestrocel Selected for CTAD 2025
    Longeveron's Laromestrocel Selected for CTAD 2025

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191065/0/en/Longeveron-Laromestrocel-Data-in-Alzheimer-s-Disease-Selected-for-Poster-Presentation-at-the-Clinical-Trials-on-Alzheimer-s-Disease-Conference-CTAD-2025.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search